Sign Up Today and Learn More About Numab Stock
Invest in or calculate the value of your shares in Numab or other pre-IPO companies through EquityZen's platform.
Numab Stock (NUMA)
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
About Numab Stock
Founded
2011
Industries
Software, Artificial Intelligence, Data and Analytics
Numab Press Mentions
Stay in the know about the latest news on Numab
J&J expands atopic dermatitis scope with $1.25bn Numab antibody purchase
pharmaceutical-technology • Jun 04, 2024
Novo Holdings portfolio company Numab Therapeutics announ...
pharmiweb • May 29, 2024
Numab Therapeutics extends partnership with Ono Pharmaceutical
startupticker • Feb 16, 2024
Physiomics inks further contract with Numab Therapeutics
marketscreener • Aug 08, 2023
Novartis’ Canakinumab Rough Patch Continues with Phase III NSCLC Flop
biospace • Aug 15, 2022
Numab Management
Leadership team at Numab
CSO, and Co-CEO, Founder
David Urech
CBO, Co-CEO, and Co-Founder
Oliver Middendorp
Join now and verify your accreditation status to gain access to:
- Numab current valuation
- Numab stock price
- Available deals in Numab and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Numab stock?
Accredited investors can buy pre-IPO stock in companies like Numab through EquityZen funds. These investments are made available by existing Numab shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Numab stock?
Shareholders can sell their Numab stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
